 |
 |
      |
|
| Arno Therapeutics is a biopharmaceutical company focused on the clinical development of targeted cancer therapies and novel drug candidates for unmet medical needs |
 |
|
|  |
|
|
 |
|
|
|
|
 |
|
May 11, 2012 Arno Therapeutics Announces Orphan-Drug Designation for AR-42 in Europe more » February 21, 2012 Arno Therapeutics Receives Two Orphan-Drug Designations for AR-42 in Treatment of Central-Nervous-System Tumors more » February 14, 2012 Arno Therapeutics Announces Exclusive Licensing Agreement with Invivis Pharmaceuticals to Develop Cancer Drug more » |
|
|
|
|
|
Arno Therapeutics, Inc. 200 Route 31 North Suite 104 Flemington, NJ 08822 (862) 703-7170 Main (973) 267-0101 Fax info@arnothera.com |
©2011 Arno Therapeutics, Inc. | Privacy Policy |